Anzeige
Mehr »
Montag, 20.04.2026 - Börsentäglich über 12.000 News
China - das Pentagon - und dieses Unternehmen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18:06Universal Music Group repurchases 920,787 shares for €18.6M
18:06BlackRock cuts stake in CVS Group below 5%
18:06Max Stock appoints two independent directors to board
18:06Jefferies reiterates Erasca stock Buy rating ahead of ASCO data
17:42RBC Capital reiterates Legend Biotech stock rating on pharma interest
17:42Mizuho reiterates BridgeBio stock rating ahead of Pfizer trial
17:42Roth/MKM raises Travelers stock price target to $345 on earnings
17:42Roth/MKM raises Silvercorp Metals stock price target on guidance
17:42Maxim Group cuts Guardian Metal Resources stock rating on revenue delay
17:42Roth/MKM raises Vicor stock price target to $245 on AI demand
17:42Albertsons stock price target lowered to $23 by Roth/MKM on costs
17:30MedPal AI issues 3.6M shares in lieu of advisory fees
17:30Inspirit Capital to acquire Kaplan Languages Group on May 1
17:30Compass Pathways stock rating reaffirmed at Buy by BTIG on regulatory outlook
17:30Evercore ISI reiterates Honeywell stock rating on portfolio sale
17:30Stifel raises Rocket Lab stock price target to $105 on space growth
17:18Informa TechTarget expands financial services coverage to UK
17:18WSFS Financial renews lease for Philadelphia office space
17:18Cosmos Health to begin Liv18 liver supplement production in April
17:18Why is Adobe stock climbing today?
17:18Scotiabank raises Nutrien stock price target on nitrogen business outlook
17:18Scotiabank cuts Mosaic stock price target on margin pressures
17:18BTIG raises Nektar Therapeutics price target to $178 on trial data
17:18Barclays cuts RadNet stock price target on consumer uncertainty
17:18Leerink reiterates Agios Pharma stock rating amid rival drug data